Healthtech
Q3 202427.08.2024

Medtech (Q3 2024)

Picture of Éanna Kelly

Éanna Kelly

at Sifted

Medtech can be a difficult nut to crack. For startups in the sector, it can take years to develop a product — and, crucially, prove that it works in a clinical setting — and high regulatory barriers can mean years more to ship it to market. For investors, that pushes exit timelines back compared to typical software-based tech investments.

But while it’s not a sector that’s been immune to the effects of the downturn — funding between 2021 and 2023 fell by nearly half — VCs are still pumping money into certain verticals.

Surgical robotics startups have been big winners in recent times, with three of the four biggest raises in the sector since the start of 2023 going to companies building tools for surgeons. There’s also buzz around next-gen diagnostics — as founders and VCs look to take advantage of the growing number of people measuring their health with devices like Apple Watches and Oura rings.

For investors that do have the patience for it, there’s a well trodden exit path to shoot for. Medtech corporates — including household names like Johnson and Johnson and Roche — are naturally acquisitive, and the 33 exits in 2023 was a record figure. These days, however, potential buyers’ appetite for risk has been clipped by the downturn and rising interest rates and big corporates are increasingly looking for later-stage startups to acquire.

While medtechs also have to contend with shifting regulations in Europe, as the region transitions to new standards, few tech sectors can count on such reliable funding for its end product. 11% of European GDP is spent on healthcare — and, according to some in the sector, buyers like national healthcare systems are increasingly recognising the potential of technology to optimise inefficient processes and address staff shortages.

20 most promising early-stage startups to watch

  • Aktiia logo

    Sifted score

    6.85
    +0.90

    Aktiia

    Accurate blood pressure monitoring solution.

    • Strong investor(s)
    • Year founded

      2018

    • HQ

      Neuchâtel, Switzerland

    • Latest round

      Early VC
      27.3m / Feb 2024

    • Total funding

      51.7m

  • Time is Brain logo

    Sifted score

    6.77
    -

    Time is Brain

    Real-time brain monitoring for specialists.

    • Strong investor(s)
    • Hiring
    • Year founded

      2020

    • HQ

      Barcelona, Spain

    • Latest round

      Grant
      2.5m / Oct 2022

    • Total funding

      8.8m

  • Invizius logo

    Sifted score

    6.75
    +0.47

    Invizius

    Targeting complement system for dialysis.

    • Strong investor(s)
    • Serial founder(s)
    • Year founded

      2018

    • HQ

      Chapelhall, United Kingdom

    • Latest round

      Grant
      1.2m / Mar 2022

    • Total funding

      12.2m

  • InVera Medical logo

    Sifted score

    6.66
    -0.21

    InVera Medical

    Non-thermal medical device for CVD.

    • Strong investor(s)
    • Year founded

      2018

    • HQ

      Galway, Ireland

    • Latest round

      Grant
      2.5m / Mar 2022

    • Total funding

      7.4m

  • AVATAR MEDICAL logo

    Sifted score

    6.54
    -

    AVATAR MEDICAL

    Customizable 3D avatars for surgery.

    • Strong investor(s)
    • Year founded

      2020

    • HQ

      Paris, France

    • Latest round

      Seed
      5m / Feb 2024

    • Total funding

      8.7m

Related Briefings

Related articles

Revolut granted French banking licence

August 10, 2026

Revolut granted French banking licence

The fintech giant is investing over €1bn in Western Europe

By Damisola Sulaiman
UK air defence startup Cambridge Aerospace hits $3.4bn valuation in new fundraise

August 10, 2026

UK air defence startup Cambridge Aerospace hits $3.4bn valuation in new fundraise

By Anne Sraders
DeepMind shakeup tests UK’s AI ambitions

August 10, 2026

DeepMind shakeup tests UK’s AI ambitions

DeepMind shakeup tests UK’s AI ambitions
By Maya Dharampal-Hornby and Martin Coulter

Pro

DeepMind’s future has become all the more critical for the UK

August 10, 2026

DeepMind’s future has become all the more critical for the UK

Headshot of John Thornhill, Sifted's cofounder and editorial director.
By John Thornhill

Pro

‘I’m not here to be acquired’: Meet Nabla’s new CEO Brian Manning

August 10, 2026

‘I’m not here to be acquired’: Meet Nabla’s new CEO Brian Manning

Brian Manning
By Daphné Leprince-Ringuet

Pro

The top junior VCs to watch in Europe, according to partners

August 7, 2026

The top junior VCs to watch in Europe, according to partners

Manal Belaouane of HV Capital
By Anne Sraders

Pro

Meet the 30+ venture scouts A16z has hunting for deals across Europe

August 7, 2026

Meet the 30+ venture scouts A16z has hunting for deals across Europe

By Maya Dharampal-Hornby

Pro

'We are more constrained by capacity than ideas': Why Lendable is chasing the superapp dream
FintechInterview

August 7, 2026

'We are more constrained by capacity than ideas': Why Lendable is chasing the superapp dream

Lenable cofounder and CEO Martin Kissinger
By Damisola Sulaiman

Pro

QMUL spinouts looking to raise
University spinoutsSpinouts fundraising

August 7, 2026

QMUL spinouts looking to raise

Sifted breaks down grant-stage to Series A spinouts from the university that are courting investors

By Oshin Narang

Pro

Inside Pleo's culture crisis: Executive exodus, unhappy staff and sale speculation
FintechInvestigations

August 7, 2026

Inside Pleo's culture crisis: Executive exodus, unhappy staff and sale speculation

Pleo cofounders Jeppe Rindom and Niccolo Perra.
By Damisola Sulaiman

Pro

UK expands talent visa to more than 100 companies

August 6, 2026

UK expands talent visa to more than 100 companies

Notably absent from the list are the country’s latest cohort of AI labs

By Freya Pratty
Europe’s 50 most active equity investors in H1 2026
Venture capitalMost active investors

August 6, 2026

Europe’s 50 most active equity investors in H1 2026

Europe’s 50 most active equity investors in H1 2026
By Federico Scolari and Oshin Narang

Pro

7 spots to meet founders and VCs in Paris

August 6, 2026

7 spots to meet founders and VCs in Paris

The bars, cafes, campuses and communities where the who’s who of French tech gathers regularly

By Daphné Leprince-Ringuet
Yann LeCun joins new VC firm

August 5, 2026

Yann LeCun joins new VC firm

This comes less than a month after the ‘AI godfather’ launched and quit Extelligence Invest

By Maya Dharampal-Hornby
Exclusive: Legaltech Wordsmith raises $14m Series B extension from Index, FT Ventures
LegaltechExclusive

August 5, 2026

Exclusive: Legaltech Wordsmith raises $14m Series B extension from Index, FT Ventures

By Maya Dharampal-Hornby

Pro

Sweaty, insane, cracked: Decoding the language of founder praise
Startup lifeAnalysis

August 5, 2026

Sweaty, insane, cracked: Decoding the language of founder praise

cracked
By Éanna Kelly and Martin Coulter
Nik Storonsky in talks over new share deal for $500bn Revolut valuation

August 5, 2026

Nik Storonsky in talks over new share deal for $500bn Revolut valuation

By Damisola Sulaiman
‘We need the bravery to change the process’: How AI is impacting physical environments

August 5, 2026

‘We need the bravery to change the process’: How AI is impacting physical environments

‘We need the bravery to change the process’: How AI is impacting physical environments
Sponsored by Nebius
Fintech startup Moss crowned Europe’s newest unicorn with €30m Series C
FintechExclusive

August 5, 2026

Fintech startup Moss crowned Europe’s newest unicorn with €30m Series C

By Damisola Sulaiman

Pro

After a decade of turning down VCs, Oxylabs hits $3.6bn valuation: 'Right timing, right partner'
DataInterview

August 5, 2026

After a decade of turning down VCs, Oxylabs hits $3.6bn valuation: 'Right timing, right partner'

Inside Oxylabs' office
By Jonathan Sinclair

Pro

The 144 new funds this year and what they reveal about Europe's investment market
FundingSifted data

August 5, 2026

The 144 new funds this year and what they reveal about Europe's investment market

Earlybird team
By Ruggero Di Spigna

Pro

A16z backs HappyRobot at $1.2bn valuation

August 4, 2026

A16z backs HappyRobot at $1.2bn valuation

The startup helps enterprises build, deploy and manage AI agents across complex workflows

By Maya Dharampal-Hornby
EU’s €5bn tech superfund officially open for business

August 4, 2026

EU’s €5bn tech superfund officially open for business

The Scaleup Europe Fund, run by EQT, will be making its first investments in the coming weeks

By Anne Sraders
Exclusive: Nscale to provide compute to Oxford, UCL and Imperial AI researchers
Exclusive

August 4, 2026

Exclusive: Nscale to provide compute to Oxford, UCL and Imperial AI researchers

By Freya Pratty

Pro